Endocrine Abstracts

Background: Continuous glucose monitoring (CGM) is an increasingly important diabetes technology that has the potential to facilitate the avoidance of low glucose values. However, there is a paucity of information on admitted patients’ characteristics, management, and outcomes of those admitted with hypoglycaemia despite being on CGM.Objective: To explore the characteristics of the patient population, precipitating factors and outcomes of people adm...

Introduction: Clinically significant hypoglycaemia, defined by blood glucose levels below 3 mmol/l (level 2) or requiring third-party assistance (level 3), poses significant risks for individuals with diabetes. However, limited information exists regarding their characteristics, management, and outcomes. The objective was to explore the characteristics, precipitating factors, and outcomes of individuals admitted with level 2 or 3 hypoglycaemia.Methods: T...

Background: Continuous Glucose Monitoring (CGM) devices are increasingly used to track blood glucose levels in individuals with diabetes. Despite widespread agreement on their benefits, limited information exists regarding the characteristics and clinical outcomes when these individuals experience hypoglycemia.Objective: To investigate the characteristics of hypoglycaemia and its outcomes in people using CGM devices.Methods: This r...